Side Effects of BPC-157 Reported side effects of BPC-157 are generally mild, and patients in our practice typically tolerate it well
Concurrent medications theoretically could affect BPC-157 pharmacokinetics through alterations in renal clearance, peptidase activity, or tissue binding
Potential interactions include: Metformin (used for type 2 diabetes) Proton pump inhibitors (PPIs) and H2-receptor antagonists (used for acid reflux) Colchicine (used for gout) Nitrous oxide (anaesthetic gas that can inactivate B12) Chloramphenicol (may reduce the haematological response to B12 therapy) If you take any of these medications long-term, discuss B12 monitoring with your healthcare provider
Sourcing GHK-Cu Australia through channels that maintain cold-chain logistics and controlled storage conditions is essential for preserving compound stability
Composed of 15 amino acids, BPC-157 is known for its stability, strong biological activity, and wide investigative interest in cell, tissue, and animal research models